Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Bipartisan efforts are underway to reform the patent system in the pharmaceutical industry, aiming to prevent companies from artificially raising drug prices. Lawmakers are pushing for legislation to encourage competition and ensure timely approvals of medications, addressing concerns about patent gaming and delayed access for consumers.
The FDA plays a vital role in developing new medications, but this is only beneficial if patients can access & afford them. Today in @EnergyCommerce, I urged my colleagues to support my legislation to encourage competition & ensure approvals are not delayed due to patent gaming. https://t.co/3ULmDG11A9
After pitched battles over Medicare drug price negotiations, Congress may be pivoting to more bipartisan ground: overhaul of the patent system that allows brand-name drugs to delay competition for years. https://t.co/qT63vJWxtN
Lawmakers across the political divide accused the #pharma industry of abusing the patent system to keep the prices of their products as high as possible at a fiery @JudiciaryDems committee hearing. https://t.co/d7voMr0Y92
